it has value only in that the alternative was liquidation. The value of the IP is probably zero. Pathway to schedule 3 is nonsense. The pathway is open to anyone with the millions to invest in a clinical trial programme to build a dossier for TGA approval. That isn’t Epsilon who doesn’t have any money and won’t because they’ve leased out the only asset they had of value.
it has value only in that the alternative was liquidation. The...
Add EPN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.208M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| EPN (ASX) Chart |
Day chart unavailable